Australian National University helped supply series A funding to scientific testing device manufacturer Liquid Instruments, which is led by a professor from the university’s College of Science.

Wren Therapeutics is commercialising Cambridge and Lund research into therapies for protein misfolding diseases, which include Alzheimer's and motor neurone disease.

Boeing HorizonX Ventures has led a series A round for the satellite terminal developer, which plans to work with the corporate's other portfolio companies in developing its technology.

Healthcare record management platform Ciitzen has received $17m in an Andreessen Horowitz-led round that included participation from Alphabet subsidiary Verily.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

The respiratory disease drug developer has collected series A funding from investors including Shionogi to fund clinical trials of its lead drug candidate .

Seed investor Pacifica returned to back the workspace provider in a series A round that will fund its expansion to approximately 50 locations in the next two years.

The respiratory disease drug developer has collected series A funding from investors including Shionogi to fund clinical trials of its lead drug candidate .

The computer vision technology developer has added a $15m second tranche backed by Qualcomm Ventures to a round that now totals $43m.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.